EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis-Reference-Cited by-同舟云学术

EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis

Published:2020-03 Issue: Volume:108 Page:102404
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Xiao Xin-yue,Li Yue-ting,Jiang Xu,Ji Xin,Lu Xin,Yang Bo,Wu Li-jun,Wang Xiao-han,Guo Jing-bo,Zhao Li-dan,Fei Yun-yun,Yang Hua-xia,Zhang Wen,Zhang Feng-chun,Tang Fu-lin,Zhang Jian-min,He Wei,Chen Hua,Zhang Xuan

Funder

National Natural Science Foundation of China

Chinese Academy of Medical Science Innovation Fund for Medical Sciences

Chinese Academy of Medical Sciences

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference60 articles.

1. Rheumatoid arthritis;Smolen;Nat. Rev. Disease Primers,2018

2. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases;Noack;Autoimmun. Rev.,2014

3. T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals;Hunt;Ann. Rheum. Dis.,2016

4. The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells;Banerjee;Cell. Immunol.,1992

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T cells: masterminds of immune equilibrium and future therapeutic innovations;Frontiers in Immunology;2024-09-03

2. Dysregulated T-cell homeostasis and decreased CD30+ Treg proliferating in aplastic anemia;Heliyon;2024-08

3. Integrated analysis of differentially m6A modified and expressed lncRNAs for biomarker identification in coronary artery disease;Cell Biology International;2024-07-14

4. Exploring the therapeutic potential of regulatory T cell in rheumatoid arthritis: Insights into subsets, markers, and signaling pathways;Biomedicine & Pharmacotherapy;2024-05

5. Dihydroartemisinin alleviates erosive bone destruction by modifying local Treg cells in inflamed joints: A novel role in the treatment of rheumatoid arthritis;International Immunopharmacology;2024-03